
Carvisyd 6.25mg Tablet
Marketer
Sydney Life Science Pvt Ltd
Salt Composition
Carvedilol (6.25mg)
Overview Carvisyd 6.25mg Tablet
Cardiovasc 6.25mg tablets effectively manage hypertension, angina pectoris, and congestive heart failure. This medication facilitates improved cardiac blood flow by promoting vasodilation. Consequently, it reduces the risk of myocardial infarction and cerebrovascular accident. Administer Cardiovasc 6.25mg with food, following your physician's prescribed dosage and regimen. Consistent use is crucial, even with symptom improvement or controlled blood pressure. Discontinuation should only occur under medical supervision to prevent potential complications. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your doctor), are highly beneficial. While generally well-tolerated, potential side effects may include vertigo, cephalalgia, dyspnea, and fatigue. Report persistent or bothersome adverse effects to your healthcare provider. Prior to commencing treatment, disclose any pre-existing cardiac or renal conditions. Furthermore, pregnant or lactating individuals should seek medical counsel before using this medication.
Uses of Carvisyd 6.25mg Tablet
Managing elevated blood pressure | Alleviating angina pectoris | Treating congestive heart failure
Major Benefits of Carvisyd 6.25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Carvisyd 6.25mg Tablet should be administered with a meal.
Common Side effects of Carvisyd 6.25mg Tablet:
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Carvisyd 6.25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 6.25mg Carvisyd tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Carvisyd 6.25mg Tablet works:
Carvisyd 6.25mg tablets combine alpha and beta-blocking actions. This dual mechanism reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Carvisyd 6.25mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Carvisyd 6.25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Lactation and Carvisyd 6.25mg tablets appear compatible. Preliminary human studies indicate minimal infant risk associated with this medication.
DrivingUNSAFE
Taking a 6.25mg Carvisyd tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Carvisyd 6.25mg tablets are considered safe, and no dosage alteration is typically necessary. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised. Routine blood pressure checks are suggested to guide any potential dosage modifications.
LiverCAUTION
Patients with liver impairment should use Carvisyd 6.25mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Carvisyd 6.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Carvisyd 6.25mg Tablet :
Should you forget a Carvisyd 6.25mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Carvisyd 6.25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Carbazole-propanol derivative |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Alpha-blocker and beta-blocker combination |
